Expect to see legislation on bipartisan issues, such as drug pricing and balance billing.
The Associated Press and broadcast networks announced on Saturday that former Vice President Joe Biden has won the 2020 presidential election.
The Trump campaign and Republican groups have initiated a number of election-related lawsuits across the battleground states, and there are also a number of formal actions that need to take place before Biden is officially considered the president-elect, including expected recounts in a number of states and the certification of votes, for which some states can take until Dec. 8 to complete.
These formal, post-election activities are expected to go forward without incident, as they have for all elections within recent memory, but, of course, this is 2020, and nothing is certain.
Assuming Biden is sworn in on Jan. 20, a priority for both Congress and the president-elect is the coronavirus. There is some chance that a relief package will be passed during the lame-duck session, as both the Republican Senate and House Democrats continue to say they want agreement on a package; however, much rests on President Trump at this point, and his goals for what happens between now and the end of January.
In terms of control of the Senate, it is currently a tie – both the Democrats and the Republicans have 48 senators each, leaving four Senate races that have yet to be concluded, including a run-off in January in Georgia for both of the state’s Senate seats.
However, whether the Democrats or the Republicans take the Senate, the impact on healthcare policy is likely to be the same under a Biden presidency. If Republicans retain their majority in the Senate, then it will be difficult for Biden to pass any major healthcare legislation, such as his proposed public option. And even if the Democrats do gain a small edge in the Senate, it will be difficult for healthcare legislation to pass without some help from moderate Senate Republicans.
That being said, we can expect to see legislation on bipartisan issues, such as drug pricing and balance billing, and Biden is expected to beef up the Patient Protection and Affordable Care Act where he can, through executive orders and regulations.
Speaking of the Affordable Care Act, lest we forget, the Supreme Court will hear arguments in the case that could overturn the act on Tuesday, Nov. 10. Many legal analysts, both those supportive and opposed to the Affordable Care Act, doubt that the court will overturn the entire law. However, like everything else this year, that is not a guarantee.
While arguments will be heard for a couple of hours Tuesday, the Supreme Court is not expected to make an actual decision on the case until June of next year.
That gives a little time for Congress to make the whole case go away by legislating a price tag on the individual mandate – say, a dollar – or repealing the individual mandate altogether. Either action from Congress would make the case moot, because the lawsuit is based on the question of what the congressional intent is with regard to the individual mandate.
However, like we said, it may be difficult for Biden to pass major healthcare legislation regardless of who runs the Senate – and, in the current political environment, mandating a dollar penalty for not buying health insurance has become a major point of contention.
Programming Note: Matthew Albright is a permanent panelist on Monitor Mondays. Listen to his legislative update sponsored by Zelis, Mondays at 10 a.m. EST.
You know, sometimes I wonder if the topics I discuss in these articles are just theoretical concepts, encompassing scenarios that never actually happen. That’s the
EDITOR’S NOTE Day 3 of the federal shutdown continues. This article by Mark Spivey is part of a special section today published by RACmonitor and
Please log in to your account to comment on this article.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
Get clear, practical answers to Medicare’s most confusing regulations. Join Dr. Ronald Hirsch as he breaks down real-world compliance challenges and shares guidance your team can apply right away.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
